Drug recall · October 11, 2023
fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 250 mL recall
Why: Lack of assurance of sterility:
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 250 mL, Total fentaNYL 500 mcg/250 mL, bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2082-2
- Lots / codes
Lot: 17-275974, 17-275979, Exp. 10/15/2023; 17-276110, Exp. 10/17/2023; 17-276234, Exp. 10/19/2023.
- Quantity
- 190 250 mL bags
- Company
- Central Admixture Pharmacy Services Inc, San Diego, CA
- Distribution
- Nationwide in the USA
- Initiated
- September 21, 2023 · Voluntary: Firm initiated
- Classified
- October 4, 2023
- Reported
- October 11, 2023
- Ended
- March 19, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bupivacaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.